Local News: Cape Verde 

 | 

Sign Up

 | 

Sign In

Advertisment

Mylan Laboratories

Mylan Laboratories News Archives

Mylan Laboratories News Archives for September 2009

Sep 28, 2009 | Business Standard

Clinton Foundation, Mylan

In a development that would enable better and more affordable treatment for HIV/AIDS patients on second-line antiretroviral therapy in the developing world, the Clinton HIV/AIDS Initiative , Mylan Inc and Hyderabad-based Matrix Laboratories have signed an agreement to offer a once-daily dose of the second-line regimen of four ARVs for under $500 ...

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, HIV/AIDS, Health, Norvir, Ritonavir (generic), Medication

Sat Sep 26, 2009

Charleston Gazette

Teacher Leadership Institutes held at lush hotel

More than 600 state teachers got to live large this summer during two weeklong Teacher Leadership Institutes hosted by the state Department of Education at the luxurious Waterfront Place Hotel in Morgantown.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pharmaceuticals, Charleston Metro

Wed Sep 23, 2009

Market Watch

S&P upgrades Mylan ratings on improved performance

Standard & Poor's said Wednesday it raised the corporate credit rating on Mylan Inc.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pharmaceuticals

Tue Sep 22, 2009

The Motley Fool

Will Teva Be Forced to Take Its Own Medicine?

Judging from the success of Teva Pharmaceutical Industries , you might say the most exalted employees are the lawyers who find ways to crack the patents of other drugmakers' products.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Food and Drug Administration, Novartis

Mon Sep 21, 2009

ThePittsburghChannel

FDA Warning: Stay Away From Stolen Respiratory Meds

The U.S. Food and Drug Administration is advising consumers not to use certain respiratory medications made by Canonsburg-based Mylan, Inc.

Comment?

Related Topix: Food and Drug Administration, Biotech, Medicine, Pharmaceuticals, Healthcare Industry

Fri Sep 18, 2009

Seeking Alpha

Tevaa s Copaxone Challenged by Mylan

Shares of generic player Teva Pharmaceuticals, Inc. were down approximately 2% on news regarding the acceptance of an abbreviated new drug application for its multiple sclerosis drug, Copaxone.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pharmaceuticals

Thu Sep 17, 2009

Tampa Bay Business Journal

FDA warns on respiratory meds stolen

The U.S. Food and Drug Administration advised consumers not to use certain respiratory medications.

Comment?

Related Topix: Food and Drug Administration, Biotech, Medicine, Healthcare Industry, Pharmaceuticals

Drug Store News

FDA tentatively approvals Matrix Labs' combination antiretroviral product

PITTSBURGH A subsidiary of a generic drug maker has received tentative approval from the Food and Drug Administration under Pres.

Comment?

Related Topix: Food and Drug Administration, HIV/AIDS, Health, Medicine, Sustiva, Efavirenz (generic), Medication, Biotech, Pharmaceuticals, Healthcare Industry

Wed Sep 16, 2009

Pharmaceutical Processing

Dey Issues Advisory Regarding Stolen Respiratory Medications

Dey L.P., a subsidiary of Mylan Inc. , today issued an advisory regarding the theft of two different types of its respiratory medications, Ipratropium Bromide Inhalation Solution, 0.02%, and Albuterol Sulfate Inhalation Solution, 0.083%, unit-dose vials.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pharmaceuticals

Tue Sep 15, 2009

Customer Interaction Solutions

www.PicksThatMove.com: 'Picks that move' Alerts, September 14, 2009:...

September 14, 2009 Mylan Inc. trading at $15.24 on a volume of 1.93M shares. In a press release out on September 14, 2009 FDA Accepts for Filing Mylan's ANDA for Generic Copaxone PITTSBURGH, Sept 14, 2009 -- Mylan Inc.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Food and Drug Administration, Regeneron Pharmaceuticals, Banking, Financial Services, Washington Federal

Mon Sep 14, 2009

MarketWatch

Israel Stocks: Israel slumps; Teva may face Mylan challenge

Israeli stocks were broadly lower Monday, reflecting weakness in all sectors but particularly in real estate and banking.

6 comments

Related Topix: Teva Pharmaceutical Industries, Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Food and Drug Administration, Israel, World News, India

Earthlink

Photographer Annie Leibovitz's loan repayment due

User Sign In Sign in now to: Personalize the content, colors, and layout of your page Choose news headlines, stock quotes, and the weather in your neighborhood Display all the links and information you need in one place Have fun! Over 50 games to play, plus My eBay and My Theaters features-all with no pop-ups! Photographer Annie Leibovitz's loan ...

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Photography, Arts, Manhattan, NY, New York, NY, Home, Mortgage

Sat Sep 12, 2009

Investopedia

Convertible Securities On The Right Track

Convertible bonds and preferred shares are among the lesser known securities available to investors.

Comment?

Related Topix: Financial Markets, Food, Agriculture, Archer Daniels Midland, Biotech, Medicine, Pharmaceuticals, Healthcare Industry

Fri Sep 11, 2009

WBOY-TV

Influential Morgantown Businessman Speaks to Professionals and Students

One of Morgantown's most prestigious businessmen spoke at the Waterfront Place Hotel this evening about capitalism and the importance of following your dreams.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pharmaceuticals

Wed Sep 09, 2009

BioSpace

Mylan Inc. Says Parting Ways with Recently Hired CFO

Mylan Inc. today announced its decision to part ways with its chief financial officer.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pharmaceuticals, Korn Ferry International, Human Resources

MarketWatch

Biotech Stocks: Drug stocks edge higher; Vivus rockets

Drug stocks edged higher in early action Wednesday as shares of Vivus Inc. rocketed on positive late-stage clinical data for its weight-loss drug Qnexa.

Comment?

Related Topix: Biotech, Medicine, VIVUS, Medical Equipment, Healthcare Industry, Pharmaceuticals

Earthlink

Michael Feinstein plans a return to Broadway

User Sign In Sign in now to: Personalize the content, colors, and layout of your page Choose news headlines, stock quotes, and the weather in your neighborhood Display all the links and information you need in one place Have fun! Over 50 games to play, plus My eBay and My Theaters features-all with no pop-ups! Michael Feinstein plans a return to ...

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry

Tue Sep 08, 2009

Med Ad News

Mark W. Parrish Joins Mylan's Board of Directors

Mylan Inc. today announced that Mark W. Parrish, chairman and CEO of Trident USA Health Services, the nation's largest provider of mobile X-ray and laboratory services to the long-term care industry, has joined Mylan's Board of Directors.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Long Term Care, Health

Sun Sep 06, 2009

TMCnet

Tuesday's Tidalwaves!!! $$$$ - (NASDAQ: FUEL) SMF Energy Corp.,...

Tuesday's Tidalwaves!!! $$$$ - SMF Energy Corp., Mylan, Inc., Orbit International Corp., Sirius XM Radio, Inc., NavStar Technologies, Inc.

Comment?

Related Topix: Oil & Gas, Streicher Mobile Fueling, Energy, Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Cable & Satellite, Orbit International, Sirius Satellite Radio, Media, Radio, Electronics, Marketing, Postal, Transportation

Fri Sep 04, 2009

Fool.com

A 1-in-100 Investor

The first 100 days in office sets the tone for any new president. Similarly, Motley Fool CAPS keeps an eye on how well investors do in their first 100 days.

Comment?

Related Topix: Financial Markets, Pfizer, Biotech, Medicine, Healthcare Industry, Food and Drug Administration, Pharmaceuticals

Wed Sep 02, 2009

Medical News

Mylan's subsidiary launches levalbuterol inhalation solution used for treating bronchospasm

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched levalbuterol inhalation solution USP , 0.25%, . Mylan, which has already launched the product, will market this product with 180 days of exclusivity.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Food and Drug Administration, Health

Also on Topix